Envoy Medical, Inc. (COCH)

Market Cap	43.32M
Revenue (ttm)	297,000
Net Income (ttm)	-23.54M
Shares Out	19.60M
EPS (ttm)	-0.21
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	10,399
Open	2.400
Previous Close	2.380
Day's Range	2.180 - 2.420
52-Week Range	0.747 - 11.720
Beta	1.24
Analysts	Strong Buy
Price Target	7.25 (+228.05%)
Earnings Date	Aug 16, 2024

About COCH

Envoy Medical, Inc., a hearing health company, focuses on providing medical technologies across the hearing loss spectrum. The company's medical technologies are designed to shift the paradigm within the hearing industry and bring providers and patients the hearing devices desire. Its products include personal sound amplification devices; hearing aids; Esteem fully implanted active middle ear implants; auditory osseointegrated implants; and Acclaim cochlear implants. The company was formerly known as Envoy Medical Corporation and changed its na...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1995
• Employees: 34
• Stock Exchange: NASDAQ
• Ticker Symbol: COCH

Financial Performance

In 2023, Envoy Medical's revenue was $316,000, an increase of 33.33% compared to the previous year's $237,000. Losses were -$29.91 million, 87.8% more than in 2022.

Analyst Forecast

According to 3 analysts, the average rating for COCH stock is "Strong Buy." The 12-month stock price forecast is $7.25, which is an increase of 228.05% from the latest price.

Price Target

$7.25

(228.05% upside)

Analyst Consensus: Strong Buy